deltatrials
Completed PHASE3 NCT00008060

Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer

Fluorouracil, Oxaliplatin and Irinotecan: Use and Sequencing: A Randomized Trial to Assess the Role of Irinotecan and Oxaliplatin in Advanced Colorectal Cancer

Sponsor: Medical Research Council

Conditions Colorectal Cancer
Interventions FOLFIRI regimen FOLFOX regimen fluorouracil irinotecan hydrochloride leucovorin calcium oxaliplatin
Updated 5 times since 2017 Last updated: Dec 18, 2013 Started: May 31, 2000 Completion: Dec 31, 2003

Listed as NCT00008060, this PHASE3 trial focuses on Colorectal Cancer and remains completed. Sponsored by Medical Research Council, it has been updated 5 times since 2000, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

May 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical Research Council
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • London, United Kingdom